NCT06838546 2025-02-20A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal CancerTasly Biopharmaceuticals Co., Ltd.Phase 2 Not yet recruiting80 enrolled